MetaCap

SpyGlass Pharma (SGP) vs Tandem Diabetes Care (TNDM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Tandem Diabetes Care is the larger company by market cap ($1.22 billion vs $1.02 billion), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SGP+15.27%TNDM-8.92%
+51%+7%-38%
Feb 6, 20261 yearNov 20, 2026
SGP+15.27%TNDM-8.92%
+44%+3%-37%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SGP versus TNDM key metrics
MetricSGPTNDM
Share price$30.43$17.46
Market cap$1.02B$1.22B
1-day change-1.14%+3.93%
YTD return—-20.56%
1-year return—-17.95%
5-year return—-86.53%
Forward P/E—195.48
EPS (TTM)$-2.70$-0.70
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.01B
Revenue growth (YoY)—+7.93%
Net income (latest FY)$-39.87M$-204.71M
Gross margin—53.81%
Operating margin—-18.45%
Net margin—-20.17%
52-week high$39.92$29.65
52-week low$17.06$12.26
Distance from 52-week high-23.77%-41.11%
Analyst consensusstrong_buybuy
Avg. price target upside+53.37%+55.21%
Average volume114.63K2.26M
Shares outstanding33.46M69.79M
Employees882,500
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About SpyGlass Pharma

SGP stock →

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Health Care · Medical/Dental Instruments · 88 employees

About Tandem Diabetes Care

TNDM stock →

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

Health Care · Medical/Dental Instruments · 2,500 employees

SGP vs TNDM FAQ

Which is bigger, SpyGlass Pharma or Tandem Diabetes Care?

Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.22B compared with $1.02B for SpyGlass Pharma (SGP).

Are SpyGlass Pharma and Tandem Diabetes Care in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons